Mercachem Holding bv:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mercachem Holding bv - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10904
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mercachem Holding BV (Mercachem) is a research company that offers transparent chemistry services. The company provides services in the areas of discovery chemistry, medicinal chemistry, parallel chemistry and process research. Its parallel chemistry services include library design, chemical validation, library synthesis and purification services. Mercachem’s process research services comprise route scouting, reaction optimization, catalyst screening, GMP production and impurity research. The company also offers optimization of lead molecules towards clinical candidates. It operates through its synthesis laboratories and analytical facility in the Netherlands. Mercachem is headquartered in Nijmegen, the Netherlands.

Mercachem Holding bv – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mercachem Holding bv, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 10
Partnerships 11
AiCuris Anti-infective Cures and Mercachem Enter into Research Agreement 11
Mercachem Forms Joint Venture with UbiQ Bio 12
Almirall Enters into Research Agreement with Mercachem 13
Mercachem Enters into Research Agreement with NB Health Lab 14
ProQinase Enters Into Co-Development Agreement With Mercachem For Drug Discovery Platform 15
Merger 16
Mercachem and Syncom Merge 16
Mercachem Holding bv – Key Competitors 17
Mercachem Holding bv – Key Employees 18
Mercachem Holding bv – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Mercachem Holding bv, Pharmaceuticals & Healthcare, Key Facts 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mercachem Holding bv, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mercachem Holding bv, Deals By Therapy Area, 2012 to YTD 2018 8
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 10
AiCuris Anti-infective Cures and Mercachem Enter into Research Agreement 11
Mercachem Forms Joint Venture with UbiQ Bio 12
Almirall Enters into Research Agreement with Mercachem 13
Mercachem Enters into Research Agreement with NB Health Lab 14
ProQinase Enters Into Co-Development Agreement With Mercachem For Drug Discovery Platform 15
Mercachem and Syncom Merge 16
Mercachem Holding bv, Key Competitors 17
Mercachem Holding bv, Key Employees 18
Mercachem Holding bv, Subsidiaries 19
Mercachem Holding bv, Joint Venture 19

List of Figures
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Mercachem Holding bv:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pieridae Energy Ltd (PEA):石油・ガス:M&Aディール及び事業提携情報
    Summary Pieridae Energy Ltd (Pieridae Energy), formerly Petrolia Inc, is an oil and gas company that develops, explores, and produces oil resources. The company’s projects comprise Haldimand project, Bourque project, Tar Point project, Corte-Real project, Anticosti project, Dalhousie project; Edgar, …
  • Getlink SE:企業の戦略・SWOT・財務分析
    Getlink SE - Strategy, SWOT and Corporate Finance Report Summary Getlink SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Ramsay Health Care Ltd (RHC):製薬・医療:M&Aディール及び事業提携情報
    Summary Ramsay Health Care Ltd (RHC) is a global healthcare group that owns and operates through healthcare facilities. Its facilities cater for a range of health care needs from day surgery procedures to complex surgeries. The company also provides psychiatric care and rehabilitation services. RHC …
  • Nippon Suisan Kaisha, Ltd.
    Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Vermilion Energy Inc (VET):石油・ガス:M&Aディール及び事業提携情報
    Summary Vermilion Energy Inc (Vermilion) is an oil and gas company that offers exploration and production services. The company is an oil and gas producer in Alberta. It offers production programs focusing on acquisition, exploration, development and optimization in North America, Europe and Austral …
  • WAVE Life Sciences Ltd (WVE):企業の財務・戦略的SWOT分析
    Summary WAVE Life Sciences Ltd (WAVE Life Sciences), formerly WAVE Life Sciences Pte Ltd is a genetic medicine company that develops stereopure nucleic acid therapies. The company's pipeline products comprise multiple oligonucleotide modalities such as exon-skipping and single-stranded RNAi, and ant …
  • ProSciento Inc-医療機器分野:企業M&A・提携分析
    Summary ProSciento Inc (ProSciento), formerly Profil Institute for Clinical Research Inc is contract research organization that concentrates on developing drugs and devices for the treatment of obesity, diabetes and metabolic diseases. The organization offers services such as clinical development an …
  • Sigla, S.A.:企業の戦略的SWOT分析
    Sigla, S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Kuros Biosciences AG (KURN):企業の財務・戦略的SWOT分析
    Kuros Biosciences AG (KURN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Delcath Systems Inc (DCTH):医療機器:M&Aディール及び事業提携情報
    Summary Delcath Systems Inc (Delcath) specializes in developing percutaneous perfusion technologies to treat primary and metastatic liver cancers. Its patented drug delivery platform delivers ultra-high doses of anti-cancer drugs to the liver, while preventing them from entering the patient's bloods …
  • Royal Boskalis Westminster NV:企業のM&A・事業提携・投資動向
    Royal Boskalis Westminster NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal Boskalis Westminster NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Sumitomo Electric Industries Ltd (5802):電力:M&Aディール及び事業提携情報
    Summary Sumitomo Electric Industries Ltd (Sumitomo) is a manufacturing company that develops, manufactures, and sells various products related to electronics, info communications, automotive, industrial materials, and environment and energy. The company’s product portfolio includes wiring harnesses, …
  • Neograft Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Neograft Technologies Inc (Neograft) is a medical device company that cardiac technologies for use in heart bypass procedures. The company offers solutions such as saphenous vein harvesting, coronary artery bypass graft, and others. It develops and provides angioshield, which is a transforma …
  • MORRE-TEC Industries, Inc.:戦略・SWOT・企業財務分析
    MORRE-TEC Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary MORRE-TEC Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Vitol Holding BV:企業の戦略的SWOT分析
    Vitol Holding BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • F. Hoffmann-La Roche Ltd:戦略・SWOT・企業財務分析
    F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report Summary F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • MAX Resource Corp. (MXR):企業の財務・戦略的SWOT分析
    MAX Resource Corp. (MXR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • QBE Insurance Group Limited:戦略・SWOT・企業財務分析
    QBE Insurance Group Limited - Strategy, SWOT and Corporate Finance Report Summary QBE Insurance Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Fonterra Co-operative Group Ltd:戦略・SWOT・企業財務分析
    Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • CMIC Holdings Co Ltd (2309):企業の財務・戦略的SWOT分析
    Summary CMIC Holdings Co Ltd (CMIC) is a contract research organization that supports drug development services. The organization offers medical research related services to pharmaceuticals and medical organizations. Its CRO business services include monitoring, data management, STAT analysis, regis …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆